Full text is available at the source.
Abstract
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are effective therapies for Type 2 diabetes mellitus (T2DM).
- Sustained glycemic control is essential for preventing long-term complications associated with T2DM.
- GLP-1 RAs have been shown to effectively manage blood sugar levels in T2DM patients.
- Traditional administration of GLP-1 RAs is via injection, which may affect patient adherence.
- Oral formulations, such as oral semaglutide, could enhance patient persistence with treatment.
Simplified